Brain Natriuretic Peptide Shows Therapeutic Potential for Acute Pulmonary Embolism
BNP reduced pulmonary artery resistance in a PE rat model and improved clinical outcomes in patients with intermediate-high-risk PE through NPRC-mediated reduction of endothelial oxidative stress.
Quick Facts
What This Study Found
BNP reduced right ventricular pressure and improved survival in PE rats, and improved clinical outcomes in intermediate-high-risk PE patients, through NPRC-mediated NADPH oxidase 2 reduction and decreased myosin light chain phosphorylation in PA smooth muscle.
Key Numbers
How They Did This
Rat PE model with autologous thrombi, BNP dose optimization, mechanistic studies (oxidative stress, NPRC signaling), and observational comparison of PE patients receiving BNP + anticoagulation vs anticoagulation alone.
Why This Research Matters
PE is the third leading cause of cardiovascular death. BNP could provide a new treatment option for intermediate-high-risk patients who are too unstable for standard therapy alone.
The Bigger Picture
This repositions BNP from a diagnostic biomarker to a therapeutic agent, demonstrating that natriuretic peptides have direct vascular therapeutic effects beyond their diagnostic utility.
What This Study Doesn't Tell Us
Small clinical observation (not randomized). Rat PE model may not fully replicate human PE. BNP dosing optimization for PE needs further study. NPRC-mediated mechanism needs human validation.
Questions This Raises
- ?Would a randomized trial of BNP in intermediate-high-risk PE confirm these benefits?
- ?What is the optimal BNP dose and infusion duration for PE treatment?
- ?Could synthetic BNP analogs with longer half-lives be more practical?
Trust & Context
- Key Stat:
- Biomarker becomes therapy BNP, traditionally measured as a diagnostic heart failure biomarker, directly treats pulmonary embolism by relaxing lung blood vessels
- Evidence Grade:
- Preclinical mechanistic study with supportive clinical observation. Novel therapeutic concept needing randomized trial confirmation.
- Study Age:
- Published in 2025.
- Original Title:
- Brain natriuretic peptide protects against acute pulmonary embolism-induced pulmonary vasoconstriction through natriuretic peptide receptor C.
- Published In:
- Basic research in cardiology (2026)
- Authors:
- Gao, Yizhuo, Liu, Shiqi, Gu, Zhichun, Wei, Xuejiao, Han, Xue, Wei, Shibo, Yang, Jing, Liu, Yuchen, Jia, Dong
- Database ID:
- RPEP-15193
Evidence Hierarchy
Frequently Asked Questions
What is BNP and how can it treat pulmonary embolism?
BNP (brain natriuretic peptide) is a natural hormone produced by the heart. While usually measured as a diagnostic test, this study shows it can actively treat PE by relaxing constricted lung blood vessels and reducing oxidative damage.
Is this treatment available now?
BNP (as nesiritide) is approved for heart failure but not yet for PE. This study provides the rationale for clinical trials testing BNP as an additional PE treatment.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15193APA
Gao, Yizhuo; Liu, Shiqi; Gu, Zhichun; Wei, Xuejiao; Han, Xue; Wei, Shibo; Yang, Jing; Liu, Yuchen; Jia, Dong. (2026). Brain natriuretic peptide protects against acute pulmonary embolism-induced pulmonary vasoconstriction through natriuretic peptide receptor C.. Basic research in cardiology. https://doi.org/10.1007/s00395-026-01166-9
MLA
Gao, Yizhuo, et al. "Brain natriuretic peptide protects against acute pulmonary embolism-induced pulmonary vasoconstriction through natriuretic peptide receptor C.." Basic research in cardiology, 2026. https://doi.org/10.1007/s00395-026-01166-9
RethinkPeptides
RethinkPeptides Research Database. "Brain natriuretic peptide protects against acute pulmonary e..." RPEP-15193. Retrieved from https://rethinkpeptides.com/research/gao-2026-brain-natriuretic-peptide-protects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.